ASX 200 (ASX:XJO) midday update: Incitec Pivot and Mesoblast jump, NAB drops

The ASX 200 has started the week strongly…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Monday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a solid gain. The benchmark index is currently up 0.4% to 7,472.9 points.

Here's what is happening on the ASX 200 today:

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.

Image source: Getty Images

Incitec Pivot results impress

The Incitec Pivot Ltd (ASX: IPL) share price jumped as much as 17% this morning following the release of its full year results. As management promised, Incitec Pivot delivered a strong second half performance. This led to the agricultural chemicals company reporting a 10% lift in full year revenue to $4,348.5 million and 91% jump in net profit after tax (NPAT) excluding individually material items to $209 million. This was driven by a strong performance from its Fertilisers APAC business, which benefited from a commodity price upswing and strong ammonium phosphates production.

Mesoblast shares jump

The Mesoblast limited (ASX: MSB) share price is charging higher today after the allogeneic cellular medicines developer released positive data from a phase three trial of rexlemestrocel-L in 565 patients with New York Heart Association (NYHA) class II and class III chronic heart failure (CHF) with reduced ejection fraction (HFrEF). Among other things, the study notes that a single dose of rexlemestrocel-L on top of standard of care reduced the incidence of heart attacks or strokes by 65% across all 537 NYHA class II or class III treated patients compared with standard of care alone.

NAB shares fall

The National Australia Bank Ltd (ASX: ANZ) share price is trading lower on Monday. However, this has nothing to do with its performance. Today's decline is attributable to the banking giant's shares trading ex-dividend for its final dividend for FY 2021. Last week NAB declared a fully franked final dividend of 67 cents per share with its full year results. Eligible NAB shareholders can look forward to receiving this dividend on 15 December.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Monday has been the Mesoblast share price with a 10% gain. This follows its trial update this morning. The worst performer on the ASX 200 has been the Ampol Ltd (ASX: ALD) share price with a decline of almost 3%. This is despite there being no news out of the fuel retailer.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A boy bounds after a big colourful bouncing ball in a grassy field.
Share Market News

ASX 200 energy shares lead and market finally cracks 8-day losing streak

The ASX 200's painful 8-day slide finally ended on Friday.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Mesoblast, Mineral Resources, and Woolworths shares

Analysts have given their verdict on these shares. Let's see what they are saying.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

These top ASX 200 shares could rise 30% to 40%

Analysts are predicting big things from these shares. Let's find out why.

Read more »

Stacks of coins in a row with each higher than the last, and a person standing on top of each one watching them grow.
Dividend Investing

How I'd invest $2,000 in high-yield ASX 300 shares

I rate these businesses as strong buys for the long-term.

Read more »

A rueful woman tucks into a sweet pie as she contemplates a decision with regret.
Share Fallers

The worst 4 ASX 200 stocks to buy and hold in April unmasked

Investors sent these four ASX 200 stocks tumbling 21% to 44% in April.

Read more »

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Share Fallers

Why these top ASX shares sank 10%+ in April

It was a tough month for these popular shares.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Buy, hold, sell: Netwealth, PLS, and Reliance shares

Morgans has given its verdict on these shares. Let's see what the broker is saying.

Read more »